Cardinal Health (CAH)

NYSE


	Symbol		Exchange		Currency
	CAH		NYSE		USD	Real-time
	CAH		TradeGate		EUR	Delayed
	CAHm		Buenos Aires		ARS	Delayed

Currency in USD

Disclaimer

110.35

+0.14(+0.13%)

Closed03/10

After Hours

110.350.00(0.00%)

03/10

Fair Value

Day's Range

109.75

110.51

52 wk Range

89.00

116.05

Cardinal Health (CAH) Income Statement & Profits

Assess the Cardinal Health Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2015

30/06

2016

30/06

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

Total Revenues

152,922

162,467

181,326

204,979

226,827

Total Revenues Growth

+5.08%

+6.24%

+11.61%

+13.04%

+10.66%

Cost Of Revenues

146,054

155,689

174,842

198,105

219,413

Gross Profit

6,868

6,778

6,484

6,874

7,414

Gross Profit Growth

+0.5%

-1.31%

-4.34%

+6.01%

+7.86%

Gross Profit Margin %

4.49%

4.17%

3.58%

3.35%

3.27%

Other Operating Expenses, Total

5,096

4,984

4,836

5,085

5,268

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.1%	-2.2%	-2.97%	+5.15%	+3.6%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,572	4,533	4,512	4,800	5,000
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

1,772

1,794

1,648

1,789

2,146

Operating Income Growth

+2.25%

+1.24%

-8.14%

+8.56%

+19.96%

EBIT Margin %

1.16%

1.1%

0.91%

0.87%

0.95%

Net Interest Expenses

-238

-180

-147

-78

-77

Net Interest Expenses Growth

+19.05%

+24.37%

+18.33%

+46.94%

+1.28%

Interest Expense, Total

-238

-180

-147

-78

-77

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

1

47

-22

-11

35

EBT, Excl. Unusual Items

1,535

1,661

1,479

1,700

2,104

Gain (Loss) On Sale Of Assets

-

-60

-

-

-

Other Unusual Items, Total

-5,764

-1,162

-64

258

-37

EBT, Incl. Unusual Items

-3,772

323

-784

663

1,201

EBT, Incl. Unusual Items Growth

-315.42%

+108.56%

-342.72%

+184.57%

+81.15%

EBT, Incl. Unusual Items Margin

-2.47

0.2

-0.43

0.32

0.53

Income Tax Expense

-79

-289

153

332

348

Net Income to Company

-3,693

612

-937

331

853

Minority Interest

-3

-1

-1

-1

-1

Net Income

-3,696

611

-938

330

852

Net Income Growth

-371.17%

+116.53%

-253.52%

+135.18%

+158.18%

Net Income Margin %

-2.42%

0.38%

-0.52%

0.16%

0.38%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-3,696

611

-938

330

852

Basic EPS - Continuing Operations

-12.61

2.09

-3.36

1.26

3.48

Basic EPS - Continuing Operations Growth

-377.64%

+116.59%

-260.67%

+137.61%

+175.04%

Diluted EPS - Continuing Operations

-12.61

2.08

-3.37

1.26

3.45

Diluted EPS - Continuing Operations Growth

-378.46%

+116.49%

-262.02%

+137.39%

+173.81%

Basic Weighted Average Shares Outstanding

293

292

279

261

245

Diluted Weighted Average Shares Outstanding

293

294

279

262

247

Dividend Per Share

1.92

1.94

1.97

1.99

2.01

Dividend Per Share Growth

+0.52%

+1.04%

+1.45%

+1%

+0.99%

EBITDA

2,685

2,577

2,340

2,481

2,856

EBITDA Growth

-1.76%

-4.02%

-9.2%

+6.03%

+15.11%

EBITDA Margin %